INTENSIVE CARE

Recommendations

Info

News Fall 2016 Mercury Medical Expands Team Mercury Enterprises has announced that John Gargaro MD has joined the Corporate Board of Directors and Douglas Smith has joined the company as Vice President of Sales and Marketing. Dr. Gargaro is currently a board certified orthopedic surgeon and graduate of Harvard University and the University of Michigan Medical School. He is currently Chief of the Department of Orthopedic Surgery at Kaiser Permanente Colorado, former Chairman of the Department of Orthopedic Surgery and former Treasurer of the Medical staff at St Joseph Hospital, Denver CO. Industry experience includes consulting positions with Wright Medical and Johnson & Johnson/DePuy, as well as clinical research and speaker panel positions for Sanofi-Synthelabo Inc. and Organon Labs. Douglas Smith’s background includes 20+ years of sales and marketing experience with GE Healthcare, Dräger, Maquet Medical Systems USA and Siemens Medical Solutions USA, Inc. Mercury Medical, a veteran-owned medical products manufacturing and marketing organization, focused on airway management and anesthesia, is recognized by the industry as a leading provider of innovative airway management devices. Neonatal Resuscitation Protocols The Helping Babies Breathe neonatal resuscitation protocol significantly reduces early neonatal deaths, according to a study from Nepal. The quality improvement approach includes identifying the barriers for health workers to adhere to neonatal resuscitation, developing an improvement plan to address the barriers as well as formation of quality improvement teams. Over a million babies worldwide die every year within a day of life, the vast majority due to birth-related complications. Resuscitation initiated within the first “golden” minute reduces deaths by 30%, the researchers explain in their paper. To improve neonatal outcomes, the simplified resuscitation protocol has been in place in many resource-poor settings. This involves keeping the baby warm, suctioning the airways, and bag and mask ventilation within the first minute, if required. Despite this, over a third of neonatal deaths in Nepal were due to intrapartum causes, casting doubts about appropriate use of the protocol. Their prospective cohort study evaluated the impact of a quality improvement cycle (QIC) at the tertiary care Paropakar Maternity and Women’s Hospital with over 22,000 babies delivered every year. The QIC was designed and planned from July to December 2012 and implemented from January to September 2013. Perinatal mortality, antepartum and intrapartum stillbirths, and first-day neonatal deaths during the two periods were compared. The QIC included a two-day training of all involved, daily bag-and-mask practice on mannequins, self-evaluation after each delivery, peer reviews after every resuscitation and refresher courses. The hospital recorded 9,588 and 15,520 deliveries during the baseline and intervention periods, respectively. Prior to the intervention, the perinatal mortality, intrapartum stillbirths, and first-day neonatal deaths were 30.9, 9.0, and 5.2 per 1,000 births, respectively. The corresponding figures during the intervention period declined to 23.3, 3.2, and 1.9, respectively (p
EVIDENCE-BASED WEBINAR Early Inhaled Nitric Oxide and Progression of Hypoxic Respiratory Failure (HRF) adpage View the webinar on-demand at INOMAX.com/earlyino page 7 Created by practitioners, for practitioners. Review various elements of HRF treatment, including: • Acute HRF in newborns • The pathophysiology of HRF • Optimizing oxygenation in HRF • Evidence for the earlier use of inhaled nitric oxide in the treatment of HRF Satyan Lakshminrusimha, MD Chief, Division of Neonatology Women and Children’s Hospital of Buffalo Ashley Darcy Mahoney, PhD, NNP-BC Neonatal Nurse Practitioner, South Dade Neonatology Assistant Professor, Emory University School of Nursing Indication INOMAX is indicated to improve oxygenation and reduce the need for extracorporeal membrane oxygenation in term and near-term (>34 weeks gestation) neonates with hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension in conjunction with ventilatory support and other appropriate agents. Important Safety Information • INOMAX is contraindicated in the treatment of neonates dependent on right-to-left shunting of blood. • Abrupt discontinuation of INOMAX may lead to increasing pulmonary artery pressure and worsening oxygenation. • Methemoglobinemia and NO 2 levels are dose dependent. Nitric oxide donor compounds may have an additive effect with INOMAX on the risk of developing methemoglobinemia. Nitrogen dioxide may cause airway inflammation and damage to lung tissues. • In patients with pre-existing left ventricular dysfunction, INOMAX may increase pulmonary capillary wedge pressure leading to pulmonary edema. • Monitor for PaO 2 , inspired NO 2 , and methemoglobin during INOMAX administration. • INOMAX must be administered using a calibrated INOmax DS IR® Nitric Oxide Delivery System operated by trained personnel. Only validated ventilator systems should be used in conjunction with INOMAX. Please see Brief Summary of Prescribing Information on adjacent page. Mallinckrodt, the “M” brand mark and the Mallinckrodt Pharmaceuticals logo are trademarks of a Mallinckrodt company. Other brands are trademarks of a Mallinckrodt company or their respective owners. © 2016 Mallinckrodt. US PRC/INOm/0616/002 July 2016 www.inomax.com
Page 1 and 2: neonatal Vol. 29 No. 4 Fall 2016 IN
Page 3 and 4: adpage page 3 NeoPAP ® infant resp
Page 5: Human milk makes all the difference
Page 9 and 10: esearchers studied 189 adults born
Page 11 and 12: DISCOVER A KINDER INCISION With Com
Page 13 and 14: of enormous importance to women and
Page 15 and 16: adpage page 15
Page 19 and 20: Interview Standards and Practices f
Page 21 and 22: adpage page 21 Getinge Group Passio
Page 23 and 24: we welcome grandparent visits if su
Page 27 and 28: BJ, Mammel MC. Laryngeal mask airwa
Page 29 and 30: Table 1. Summary of Blood Gas in co
Page 31 and 32: On day of life 23, the infant trans
Page 33 and 34: adpage page 33 Simple, versatile...
Page 35 and 36: Umbilical Cord Knot Leading To Feta
Page 37 and 38: knot and obstetric outcome. Int J G
Page 39 and 40: hesitant and the probable reason th
Page 41 and 42: What Mattered Most: From NICU Pump
Page 43 and 44: What mattered most during the busy
Page 45 and 46: groups VAS at birth OPV at birth (N
Page 47 and 48: Table 3 The fraction of dead/enroll
Page 49 and 50: a clear inversion of the pattern be
Page 51 and 52: andomized, double-masked trial in N
Page 53 and 54: Essential Childbirth And Postnatal
Page 55 and 56: evidence concerning the role of rou
Page 57 and 58:
Zupan 2004 [60] To assess the effec
Page 59 and 60:
to hypothermia, consideration shoul
Page 61 and 62:
directly proportional to the level
Page 63 and 64:
adequate delivery of health-care so
Page 65 and 66:
68. Lee A, Cousens S, Wall A, Nieme
Page 67 and 68:
*Picture to be replaced adpage page
show all

INTENSIVE CARE

Create successful ePaper yourself

Delete template?

Save as template ?